The DSPP gene dentinogenesis imperfecta Shields type 3 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the DSPP gene, which are responsible for causing Dentinogenesis Imperfecta Type III. This rare genetic disorder affects the development of dentin, a hard, dense, bony tissue forming the bulk of a tooth beneath the enamel. Individuals with Dentinogenesis Imperfecta Type III may experience discolored, weak, or brittle teeth, leading to significant dental issues and affecting overall oral health.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing, ensuring high standards of accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise involved in identifying the specific genetic mutations of the DSPP gene. This test is crucial for early diagnosis and management of the condition, allowing for tailored dental care and treatment plans to improve the quality of life for affected individuals.
The FLG Gene Dermatitis Atopic Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FLG gene which are associated with atopic dermatitis type 2. Atopic dermatitis, also known as eczema, is a chronic skin condition characterized by dry, itchy, and inflamed skin. The FLG gene plays a critical role in skin barrier function, and mutations in this gene can lead to a compromised skin barrier, making individuals more susceptible to atopic dermatitis and related skin conditions.
This genetic test is crucial for individuals with a family history of atopic dermatitis or those exhibiting symptoms, as it can provide a definitive diagnosis and help in tailoring personalized treatment plans. Early detection and understanding of the genetic basis of the condition can significantly improve management strategies and quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the FLG Gene Dermatitis Atopic Type 2 Genetic Test is 4400 AED, reflecting the specialized nature of the test and the comprehensive analysis involved. Upon opting for this test, individuals can expect a professional and supportive experience, with results that offer valuable insights into their condition and how best to manage it.
The KRT14 Gene Dermatopathia Pigmentosa Reticularis Genetic Test is a specialized diagnostic procedure designed to detect mutations in the KRT14 gene, which are responsible for the rare genetic skin disorder known as Dermatopathia Pigmentosa Reticularis (DPR). DPR is characterized by a triad of symptoms: reticulate hyperpigmentation, noncicatricial alopecia, and onychodystrophy. This condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. By analyzing a patient's DNA sample, usually obtained through a blood draw or cheek swab, the test can identify specific mutations in the KRT14 gene that are indicative of DPR. This genetic confirmation is crucial for accurate diagnosis, allowing for appropriate management and counseling for affected individuals and their families.
The cost of the KRT14 Gene Dermatopathia Pigmentosa Reticularis Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the genetic mutation associated with DPR, offering patients and healthcare providers vital information for the management of the condition.
The "MTAP Gene Diaphyseal Medullary Stenosis with Malignant Fibrous Histiocytoma Genetic Test" is a sophisticated diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MTAP gene that are linked to diaphyseal medullary stenosis with malignant fibrous histiocytoma. This rare genetic condition is characterized by the narrowing of the medullary cavities of the long bones and the potential development of a highly aggressive form of cancer known as malignant fibrous histiocytoma. The test, which costs 4400 AED, plays a crucial role in the early detection and management of the disease, providing essential information for personalized treatment plans. By analyzing the patient's DNA, the test helps in understanding the genetic basis of the condition, facilitating targeted therapies and informed clinical decisions. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a significant advancement in the field of personalized medicine and genetic diagnostics.
The "MYO5B Gene Diarrhea Type 2 with Microvillus Atrophy Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the MYO5B gene. These mutations are known to cause a rare but severe disorder characterized by diarrhea and microvillus atrophy, a condition where the microscopic hair-like structures (microvilli) that line the intestine and aid in nutrient absorption are absent or abnormal. This genetic test is crucial for early diagnosis and management of the condition, which can significantly impact a patient's quality of life. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. By identifying the genetic basis of the disorder, healthcare providers can tailor treatment plans more effectively, offering hope to affected individuals and their families.
The GUCY2C gene diarrhea type 6 genetic test is a specialized diagnostic tool designed to identify mutations in the GUCY2C gene, which can lead to familial diarrhea syndrome 6 (FDS6). This condition is characterized by chronic diarrhea and various gastrointestinal issues starting from infancy or early childhood. The test is crucial for confirming the diagnosis, understanding the genetic basis of the disorder, and guiding treatment decisions.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA sample to detect specific mutations in the GUCY2C gene that are known to cause the disorder. With a cost of 4400 AED, the test is a valuable resource for affected families seeking answers and medical professionals looking for a definitive diagnosis to tailor the most effective management plans for their patients.
By opting for this test at DNA Labs UAE, individuals can benefit from the lab's expertise in genetic testing, ensuring accurate and reliable results. The test not only aids in the diagnosis but also helps in risk assessment for family members, contributing to better-informed healthcare decisions and personalized care for those affected by familial diarrhea syndrome 6.
The ABCB6 gene dyschromatosis universalis hereditaria type 3 (DUH3) genetic test is a specialized diagnostic tool designed to identify mutations in the ABCB6 gene, which are associated with dyschromatosis universalis hereditaria type 3. This rare genetic disorder is characterized by abnormal pigmentation of the skin, with both hyperpigmented and hypopigmented patches distributed over the body. The test is crucial for confirming a clinical diagnosis of DUH3, enabling appropriate management and counseling for affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the ABCB6 gene test employs advanced genomic technologies to ensure accurate and reliable results. The test cost is 4400 AED, reflecting the comprehensive nature of the analysis and the expertise involved in interpreting the results. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect high-quality service and support throughout the diagnostic process, from sample collection to result interpretation and beyond.
The NOP10 Gene Dyskeratosis Congenita Autosomal Recessive Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the NOP10 gene, which are linked to Dyskeratosis Congenita, a rare, inherited bone marrow failure syndrome. This condition is characterized by the triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia, along with a range of other potential systemic manifestations. It primarily follows an autosomal recessive inheritance pattern, meaning that individuals must inherit two copies of the mutated gene, one from each parent, to manifest the disease.
The test, available at DNA Labs UAE, is crucial for early diagnosis, which can significantly impact the management and prognosis of the condition. It involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific mutations in the NOP10 gene. A positive result may confirm the diagnosis of Dyskeratosis Congenita, facilitating appropriate clinical management and genetic counseling for affected individuals and their families.
The cost of the NOP10 Gene Dyskeratosis Congenita Autosomal Recessive Type 1 Genetic Test at DNA Labs UAE is 3200 AED. This investment in health allows for the precise identification of the genetic basis of the condition, which is essential for understanding the disease's progression, potential complications, and informing decisions regarding surveillance and treatment strategies tailored to the individual's genetic makeup.
The NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the NHP2 gene that are associated with Dyskeratosis Congenita (DC), specifically the autosomal recessive type 2 variant of the disease. DC is a rare, genetically inherited disorder characterized by the premature aging of cells and tissues, leading to symptoms such as skin abnormalities, nail dystrophy, and bone marrow failure. The test plays a critical role in the early detection and management of the condition, allowing for timely intervention and genetic counseling. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED, reflecting the comprehensive analysis and precision involved in diagnosing this complex condition.
Dyskeratosis Congenita (DC) is a rare, genetically heterogeneous disorder characterized by the triad of reticulated skin pigmentation, nail dystrophy, and oral leukoplakia. Bone marrow failure, pulmonary complications, and an increased risk of malignancies are serious health concerns associated with this condition. The disease manifests in various forms, including autosomal recessive type 4 and autosomal dominant type 2, both of which are linked to mutations in the TERT gene. The TERT gene plays a crucial role in maintaining telomere length, which is essential for chromosome stability and cellular lifespan.
To diagnose and differentiate between the types of Dyskeratosis Congenita, particularly those associated with TERT gene mutations, genetic testing is pivotal. DNA Labs UAE offers a comprehensive genetic test for this purpose. The test specifically identifies mutations in the TERT gene that are known to cause autosomal recessive type 4 and autosomal dominant type 2 Dyskeratosis Congenita. This precise genetic testing can aid in the accurate diagnosis of the disease, which is crucial for the management and treatment planning for affected individuals.
The cost of the TERT gene Dyskeratosis Congenita genetic test at DNA Labs UAE is 4400 AED. The test is conducted under stringent quality control measures to ensure accuracy and reliability of the results. Individuals who have a family history of Dyskeratosis Congenita or exhibit symptoms consistent with the disorder may consider undergoing this genetic test. Early diagnosis through genetic testing can significantly impact the clinical management and improve the quality of life for those affected by this challenging condition.
